Biolase Technology, Inc. (BIOL) Tops Q4 EPS by 5c, Guides FY Rev Above Street
Tweet Send to a Friend
Biolase Technology, Inc. (NASDAQ: BIOL) reported Q4 EPS of $0.05, $0.05 better than the analyst estimate of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
